Neurogenetics is a new field of science that aims to better understand the causes of brain and nerve illnesses by utilising current developments in genome sequencing. A branch of research aimed at better understanding the genetic roots of mental illnesses. The role of genetics in the development and function of the nervous system is studied in neurogenetics. It treats neural traits as phenotypes and is based on the observation that individuals' neurological systems, even within the same species, are not always identical. As the name implies, it incorporates elements from both neuroscience and genetics research, with a special focus on how an organism's genetic code influences its manifested features. Neurogenetics is used to investigate neurological illnesses, behaviour, and personality. Neurogenetics is also assisting in the advancement of the individualised clinical care paradigm. Physicians can build highly personalised treatment programmes for each patient based on a thorough understanding of their genetic profile and medical history.

•    Autism spectrum disorder
•    Brain malformations
•    Developmental delay 
•    Intellectual and cognitive disability 
•    Neurologic disorders in children
•    Pediatric Genetic Counseling.
•    Molecular diagnosis and therapeutic approaches
•    Gentetic testing and screening

Market Analysis : According to Persistence Market Research's newest research, the neurogenetic testing market is expected to develop at a CAGR of 7% from 2021 to 2031. Neurogenetic disorder is caused by a mutation in one or more genes that impact the neurological system. Dementia, genetic neuropathy, Parkinson's disease, epilepsy, and other neurological illnesses are examples. Advancements in DNA sequencing technology and increased research in the life science area are driving the Neurogenetic Testing market. These techniques provide a precise therapy plan for the disease. The increasing frequency of neurological illnesses, public awareness of genetic screening, availability of current diagnostic technologies, and increased life science R&D are the main drivers of demand for neurogenetic testing. DNA sequencing is undergoing a number of technological breakthroughs.

Neurology Conferences 2022 Neurodegenerative Disorders Conferences Neurology Conferences Neurology Conferences 2022 Japan Cerebrovascular Disease Conferences Brain Cancer Conferences Neurological Disorders Conferences Parkinson Disease Conferences Alzheimer's Disease Conferences Seizures Conferences Epilepsy Conferences Headache Conferences Clinical Neurology Conferences Neurosurgery Conferences Neurology Conferences 2022